• Arteris, Inc. recently reported its second-quarter 2026 results, with revenue rising to US$24.13 million while net loss widened to US$14.07 million, and updated its 2026 revenue outlook to US$95.0 million–US$98.0 million alongside appointing Saurabh Sinha as its new Chief Financial Officer effective September 8, 2026.
• The combination of faster revenue growth, continued losses, and a change in financial leadership gives investors fresh information on both operating momentum and how capital allocation might be managed going forward.
• We’ll now examine how Arteris’ stronger top-line guidance but larger losses, alongside its new CFO, affect the existing investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 56 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Arteris Investment Narrative Recap

To own Arteris, you have to believe that rising demand for its network on chip IP and growing contract base can eventually support a path toward sustainable earnings. The latest quarter reinforced that tension: revenue is accelerating, but losses are getting larger. For now, this news mostly sharpens the existing near term trade off between top line momentum as a key catalyst and ongoing operating losses as the central risk, rather than fundamentally changing it.

The most relevant update is Arteris lifting its 2026 revenue outlook to US$95.0 million to US$98.0 million after delivering US$24.13 million in Q2 sales. That stronger guidance directly ties into the growth catalyst around expanding AI and chiplet design activity. At the same time, the wider net loss of US$14.07 million underlines how much execution is still needed before higher revenue can meaningfully relieve pressure on margins and cash burn.

Yet behind the stronger revenue guidance, the growing net losses highlight a risk investors should be aware of if...

Arteris’ narrative projects $163.3 million revenue and $18.5 million earnings by 2029.

Uncover how Arteris' forecasts yield a $41.00 fair value, a 59% upside to its current price.

Exploring Other Perspectives

Compared with the baseline story, the most cautious analysts were already assuming around US$149.4 million of revenue by 2029, yet still no profitability, which shows how differently you and others might weigh Arteris’s rising losses against its AI related growth potential.

Explore 5 other fair value estimates on Arteris - why the stock might be worth over 2x more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Arteris research is our analysis highlighting 3 key rewards and 4 important warning signs that could impact your investment decision.
• Our free Arteris research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Arteris' overall financial health at a glance.

Looking For Alternative Opportunities?

Our top stock finds are flying under the radar-for now. Get in early:

• Outshine the giants: these 17 early-stage AI stocks could fund your retirement.
• Rare earth metals are the new gold rush. Find out which 28 stocks are leading the charge.
• The future of work is here. Discover the 37 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.